Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Organon & Co. (NY: OGN ) 16.04 -0.08 (-0.50%) Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,570,213 Open 16.19 Bid (Size) 16.08 (1) Ask (Size) 16.20 (1) Prev. Close 16.12 Today's Range 15.95 - 16.27 52wk Range 10.84 - 23.10 Shares Outstanding N/A Dividend Yield 6.98% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Looking Into Organon's Recent Short Interest November 07, 2024 Via Benzinga Update on FDA Review of VTAMA® (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older November 05, 2024 From Organon & Co. Via Business Wire Performance YTD +9.04% +9.04% 1 Month -10.79% -10.79% 3 Month -17.57% -17.57% 6 Month -23.40% -23.40% 1 Year +44.24% +44.24% More News Read More Organon Reports Results for the Third Quarter Ended September 30, 2024 October 31, 2024 From Organon & Co. Via Business Wire US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab) October 30, 2024 From Organon & Co. Via Business Wire P/E Ratio Insights for Organon October 02, 2024 Via Benzinga 3 Cheap High Dividend Stocks For Passive Income August 30, 2024 Via Talk Markets Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1% October 28, 2024 From Organon & Co. Via Business Wire Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1% October 28, 2024 From Roivant Sciences Via GlobeNewswire Want $300 in Dividends Every Month? Invest $20,000 in Each of These 3 Stocks October 24, 2024 Via The Motley Fool Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q4 October 22, 2024 Via Benzinga Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields October 21, 2024 Via Benzinga Organon to Report Third Quarter 2024 Results and Host Conference Call on October 31, 2024 October 09, 2024 From Organon & Co. Via Business Wire Organon, Howmet Aerospace And More: CNBC's 'Final Trades' October 03, 2024 Via Benzinga Primary Endpoint Met in Phase 3 Comparative Clinical Study of Perjeta® (pertuzumab) Biosimilar Candidate HLX11 September 30, 2024 From Organon & Co. Via Business Wire Week In Review: Nippon Shinyaku Signs $735 Million Deal For DMD Therapy September 21, 2024 Via Talk Markets Roivant Sciences Offloads Psoriasis Medicine Maker To Organon For Up To $1.2B September 18, 2024 Via Benzinga Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1% September 18, 2024 From Organon & Co. Via Business Wire Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1% September 18, 2024 From Roivant Sciences Via GlobeNewswire JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability September 06, 2024 Via Benzinga Organon Stock Sees Relative Strength Rating Rise To 91 August 27, 2024 Via Investor's Business Daily Organon Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold August 20, 2024 Via Investor's Business Daily Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets August 20, 2024 From Organon & Co. Via Business Wire OGN Stock Earnings: Organon Beats EPS, Misses Revenue for Q2 2024 August 06, 2024 Via InvestorPlace Organon Reports Results for the Second Quarter Ended June 30, 2024 August 06, 2024 From Organon & Co. Via Business Wire Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount' July 30, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
